3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
4
Rhabdoid Tumor
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Neuroblastoma
4
Medulloblastoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Histiocytosis, Langerhans-Cell
4
Hepatoblastoma
4
Glioma
4
Ependymoma
4
Sarcoma
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Multiple Myeloma
3
Central Nervous System Neoplasms
3
Sarcoma, Ewing
2
Xanthogranuloma, Juvenile
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Interventions
Cyclophosphamide
34
fludarabine
25
fludarabine phosphate
24
Tacrolimus
24
Mycophenolic Acid
23
Whole-Body Irradiation
22
Busulfan
15
Methotrexate
12
Melphalan
12
Granulocyte Colony-Stimulating Factor
12
Antilymphocyte Serum
12
thymoglobulin
11
Cyclosporine
11
Stem Cell Transplantation
10
Filgrastim
10
Rituximab
9
Thiotepa
7
Peripheral Blood Stem Cell Transplantation
7
Nivolumab
7
Dexamethasone
7
trametinib
6
Radiotherapy
6
Mesna
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
Bortezomib
5
Azacitidine
5
Alemtuzumab
5
Voriconazole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hematologic Neoplasms
×
Nuclear Medicine Department, Hospital
×
Clear all
No trials found.